Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human FCRL1/FcRH1 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB2049
This item is not returnable.
View return policy
Description
FCRL1/FcRH1 Monoclonal specifically detects FCRL1/FcRH1 in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.Specifications
FCRL1/FcRH1 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
Q96LA6 | |
FCRL1 | |
Mouse myeloma cell line NS0-derived recombinant human FCRL1/FcRH1 Ala17-His304 Accession # Q96LA6 | |
100 μg | |
Primary | |
Detects human FCRL1/FcRH1 in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant human (rh) FCRL2, 3, 4, or 5 is observed. | |
Human | |
Purified |
Western Blot, Flow Cytometry, CyTOF | |
282415 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
BXMH1, CD307a, CD307a antigen, Fc receptor homolog 1, Fc receptor-like 1, FcRH1, FCRH1DKFZp667O1421, FcRL1, FcR-like protein 1, hIFGP1, IFGP family protein 1, IFGP1, IFGP1Fc receptor-like protein 1, Immune receptor translocation-associated protein 5, IRTA5, IRTA5immunoglobulin superfamily Fc receptor, gp42 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
115350 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction